A phase II trial of alternating cycles of carboplatin/paclitaxel and carboplatin/gemcitabine for stage IIIB/IV non-small cell lung cancer

被引：0
|
作者：
Ahmad, I. [1 ]
Arnold, F. [1 ]
Ahmed, S. [1 ]
Sami, A. [1 ]
Zhu, T. [1 ]
Haider, K. [1 ]
Yadav, S. [1 ]
Gesy, K. [1 ]
Brigden, M. [1 ]
机构：
[1] Saskatoon Canc Ctr, Saskatoon, SK, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19113
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pemetrexed plus carboplatin versus gemcitabine plus carboplatin in the treatment of stage IIIB/IV non-small cell lung cancer
    Gronberg, B. H.
    Bremnes, R.
    Aasebo, U.
    Brunsvig, P.
    Flotten, O.
    Hjelde, H.
    Wammer, F.
    Stornes, F.
    Tollali, T.
    Sundstrom, S. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Randomized phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small cell lung cancer (NSCLC)
    Saleh, M. N.
    Socinski, M. A.
    Trent, D.
    Dobbs, T.
    Zehngebot, L. M.
    Levine, M. A.
    Stella, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Phase II trial of carboplatin plus cetuximab for the treatment of stage IIIB/IV non-small cell lung cancer (NSCLC)
    Bradford, D. S.
    Socinski, M. A.
    LaRocca, R. V.
    Hensing, T. A.
    Bordoni, R. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
  • [5] Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer
    Sovak, Mika A.
    Lutzker, Stuart
    Zheng, Ling
    Guensch, Lisa
    Joyce, Margaret
    Schwartz, Susan
    Wu, Yujun
    Aisner, Joseph
    LUNG CANCER, 2006, 53 (02) : 177 - 181
  • [6] Carboplatin and gemcitabine in the palliative treatment of stage IV non-small cell lung cancer: Definitive results of a phase II trial
    Tassinari, D
    Fochessati, F
    Arcangeli, V
    Sartori, S
    Agostini, V
    Fantini, M
    Genestreti, G
    Grassia, S
    Ioli, G
    Imola, M
    Iorio, D
    Mianulli, AM
    Monticelli, G
    Oliverio, G
    Panzini, I
    Papi, M
    Poggi, B
    Polselli, A
    Pulini, S
    Tamburini, E
    Fattori, PP
    Ravaioli, A
    TUMORI JOURNAL, 2004, 90 (01): : 54 - 59
  • [7] Phase II study of navelbine and carboplatin in stage IIIB and IV non small cell lung cancer
    Chetiyawardana, AD
    Grove, N
    Faulk, S
    THORAX, 2001, 56 : 69 - 69
  • [8] A randomized phase II trial comparing pulsed erlotinib before or after carboplatin and paclitaxel in patients with stage IIIB or IV non-small cell lung cancer
    Riely, G. J.
    Rudin, C. M.
    Kris, M. G.
    Senturk, E.
    Azzoli, C. G.
    Brahmer, J.
    Fogle, M.
    Ginsberg, M.
    Miller, V. A.
    Rizvi, N. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer:: a phase III randomized trial
    Zatloukal, P
    Petruzelka, L
    Zemanová, M
    Kolek, V
    Skricková, J
    Pesek, M
    Fojtu, H
    Grygárková, I
    Sixtová, D
    Roubec, J
    Horenková, E
    Havel, L
    Prusa, P
    Nováková, L
    Skácel, T
    Kuta, M
    LUNG CANCER, 2003, 41 (03) : 321 - 331
  • [10] Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer
    Abratt, Raymond P.
    Lee, Jung Sin
    Han, Ji Youn
    Tsai, Chun-Ming
    Boyer, Michael
    Mok, Ton
    Kim, Sang-We
    Lee, Jin Soo
    Brnabic, Alan J. M.
    Reece, William H. H.
    Lehnert, Manfred
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 135 - 140
12345